14th Injectables Summit

The drive for at-home patient care, high-volume injectables and evolving regulations is driving the injectables landscape. Recent innovations from the FDA's groundbreaking human factor guidance for combination products to GSK's trailblazing strides in self-administered HIV medication, and MIT engineers' visionary work on implantable devices for diabetes, signal unparalleled momentum. The past 12 months have witnessed an electrifying surge in quality standards and ingenious device inventions, but challenges still persist in device design and development. In 2024, with a renewed dedication to addressing key industry challenges, the 14th Injectables Summit stands as the premier gathering of experts, singularly committed to optimizing the journey of biopharma's injectable device development. From seamless drug-product device integration to meticulous validation and verification processes, our summit showcases state-of-the-art devices and intricate formulations, all with a steadfast focus on prioritizing patient usability. Discuss innovations across next generation devices, high viscosity drugs, AI integration and more by sparking conversations with 80+ experts amongst Merck, Novo Nordisk, and Regeneron with 3 days of packed technical content. Whether you are in Device Design, Engineering, Integration, this is your ultimate opportunity to unite with leading minds at one of the longest standing communities this October. Don’t miss your chance to streamline your injectable combination device, with technical takeaways and practical learnings from your peers in the field.

Event Links

Website: https://go.evvnt.com/2468798-0

Tickets: https://go.evvnt.com/2468798-2

Brochure: https://go.evvnt.com/2468798-3

Read More

View Less